OUR PRODUCTS

MOBILE APPS

GENERAL INFO

HALO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Halozyme Therapeutics (HALO) Earnings Date & Reports

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

HALO is expected to report earnings to fall 5.19% to $1.46 per share on November 10

Halozyme Therapeutics HALO Stock Earnings Reports

Q3'25

Est.

$1.46

Q2'25

Beat

by $0.30

Q1'25

Beat

by $0.13

Q4'24

Beat

by $0.11

Q3'24

Beat

by $0.31

The last earnings report on August 05 showed earnings per share of $1.54, beating the estimate of $1.24. With 1.67M shares outstanding, the current market capitalization sits at 7.87B.

View a ticker or compare two or three

Compare

HALO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For HALO
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HALO showed earnings on August 05, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

12390 El Camino Real

Phone

+1 858 794-8889

Employees

373

Web

https://www.halozyme.com